Insider Cluster (2 insiders) ·Filed Jul 27, 2026

CYTK

CYTOKINETICS INC
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $889K total
Actionable Insight • Neutral

The insider sales are routine and immaterial relative to CYTK's $10B market cap. The CEO's cashless exercise is standard practice. Monitor the next 8-K or press release for any material corporate developments, but this cluster alone does not warrant a trading response.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
CYTK ▼ -4.38% at T+20d
NEUTRAL call ✗ call lost -4.38% · α vs SPY -7.68% · entry $80.62 → $77.09
Next anchor: T+60d in 17d
Latest observation: T+46 -36.44% FF3 residual α
Entry anchored
Jul 24, 03:59 PM ET
via exchange tick
T+1d
-1.45%
call -1.45% · α -1.69%
$79.45
settled 2mo ago
T+5d
-4.33%
call -4.33% · α -5.40%
$77.13
settled 2mo ago
T+20d
-4.38%
call -4.38% · α -7.68%
$77.09
settled 6w ago
T+60d
—
call — · α —
—
in 17d

Price Chart

Loading chart...

Executive Summary

CEO Robert Blum exercised 7,500 options at $10.60 and immediately sold the shares at $80.87 for $607K in proceeds, while EVP R&D Fady Malik sold 3,500 shares at $80.59 for $282K. The $889K total open-market sales represent ~0.009% of CYTK's $10B market cap — a trivial amount. The CEO's same-day exercise-and-sell pattern is a routine cashless exercise, not a bearish signal. The cluster is non-informative given the trivial proportionality and the liquidity-driven nature of the sales.

Key Financial Metrics

Direction
selling
Total Value
$889.0K
Insiders
2

Key Facts

  • CEO Blum exercised 7,500 options at $10.60 and sold the resulting shares at $80.87 for $607K in proceeds
  • EVP R&D Malik sold 3,500 shares at $80.59 for $282K
  • Total open-market sales of $889K represent ~0.009% of CYTK's $10B market cap
  • CEO's same-day exercise-and-sell is a routine cashless exercise, not an informed sale
  • No open-market purchases in the cluster

Financial Impact

Trivial — $889K in sales is ~0.009% of market cap

insider ownership

Risk Factors

  • Insider sales are not predictive of near-term stock performance at this trivial proportionality level
  • CEO's exercise-and-sell pattern is liquidity-driven, not informational

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (28 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-CYTK-1785214911226
32 reports for CYTK
Performance horizon
89% Hit rate 8 of 9 directional calls best @ T+20▲ +10.38%Mar 31, 2026
Filters
Rows
Reports for CYTK — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
BEARISH ★ 5/10
$69.31 $67.59▲ +2.48%▲ +4.59%$65.60 (+5.35%)
Sep 11, 2026
20d ago
Insider Cluster
NEUTRAL ★ 2/10
$72.45 $67.56▼ −6.75%▼ −6.86%$65.60 (−9.45%)
Sep 1, 2026
4w ago
Insider Cluster
NEUTRAL ★ 2/10
$71.40 $74.11▲ +3.80%▲ +3.71%$65.60 (−8.12%)
Aug 31, 2026
4w ago
Insider Cluster
NEUTRAL ★ 3/10
$71.40 $74.11▲ +3.80%▲ +3.71%$65.60 (−8.12%)
Aug 29, 2026
4w ago
Press Release
BULLISH ★ 7/10
$70.91 $75.35▲ +6.26%▲ +6.40%$65.60 (−7.49%)
Aug 28, 2026
5w ago
8-K
BULLISH ★ 7/10
$72.09 $72.72▲ +0.87%▲ +0.76%$65.60 (−9.00%)
Jul 30, 2026
9w ago
Insider Cluster
NEUTRAL ★ 2/10
$80.42 $81.37▲ +1.18%▼ −2.44%$65.60 (−18.43%)
Jul 27, 2026
9w ago
Insider Cluster
NEUTRAL ★ 2/10
$80.62 $77.13▼ −4.33%▼ −5.40%$65.60 (−18.63%)
Jul 23, 2026
10w ago
Press Release
NEUTRAL ★ 2/10
$80.74 $80.42▼ −0.40%▼ −0.77%$65.60 (−18.75%)
Jul 14, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$81.93 $79.11▼ −3.44%▼ −2.15%$65.60 (−19.93%)
Showing 10 of 32

US Market Status

Market Closed — Opens Mon (65h)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 28, 2026